Concepedia

Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial

Ligia Petrică, Maxim Petrica, Adrian Vlad, Dragoş Cătălin Jianu, Gheorghe Gluhovschi, Calina Ianculescu, Victor Dumitraşcu, Sorin Giju, Cristina Gluhovschi, Flaviu Bob,

Wiener klinische Wochenschrift · 2009 · 37 citations · 52 references

References

52

Diabetes and cardiovascular disease. The Framingham study

William B. Kannel · JAMA · 1979 · 4K citations

Medicine, Cardiology, Endocrinology +17

Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Andrew S. Levey, Kai‐Uwe Eckardt, Yusuke Tsukamoto et al. · Kidney International · 2005 · 3.9K citations · Full text

Medicine, Internal Medicine, Nephrology +17

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

Steven E. Kahn, Steven M. Haffner, Mark Heise et al. · New England Journal of Medicine · 2006 · 2.9K citations

Medicine, Endocrinology, Pharmacotherapy +13

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

L Rydén, Eberhard Standl, M. Bartnik et al. · European Heart Journal · 2006 · 1.7K citations · Full text

Medicine, Cardiology, Endocrinology +17

Nephropathy in Diabetes

Diabetes Care · 2004 · 1K citations